Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-KB and AP-1

British Journal of Pharmacology

Volumn 157, Issue 3, 2009, Pages 436-450

  Sutcliffe, Amy M ^a   Clarke, Deborah L ^b   Bradbury, Dawn A ^a   Corbett, Lisa M ^a   Patel, Jamie A ^a   Knox, Alan J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Activator protein 1; Asthma; Endothelin 1; G protein coupled receptor; Inflammation; Mitogenactivated protein kinase; Monocyte chemotactic protein 1; Nuclear factor kb; Transcription factor

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; CCL2 PROTEIN, HUMAN;

ARTICLE; BASE PAIRING; CELL VIABILITY; CONSENSUS SEQUENCE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN SECRETION; REPORTER GENE; RNA STABILITY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; START CODON; TRANSCRIPTION REGULATION; TRANSLATION INITIATION; UPREGULATION; CELL CULTURE; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY; RESPIRATORY SYSTEM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIN-1; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 70349908064     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00143.x     Document Type: Article

References (79)

1. Adner M, Cardell LO, Sjoberg T, Ottosson A, Edvinsson L (1996). Contractile endothelin-B (ETB) receptors in human small bronchi. Eur Respir J 9: 351-355. (Pubitemid 26068631)
2. Alexander SPH, Mathie JA, Peters A (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2): S1-S209.
3. Arcaro A, Wymann MP (1993). Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J 296 (Pt 2): 297-301. (Pubitemid 23350826)
4. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H et al. (2007). The selectivity of protein kinase Inhibitors: a further update. Biochem J 408: 297-315.
5. Barnes PJ, Chung KF, Page CP (1998). Inflammatory mediators of asthma: an update. Pharmacol Rev 50: 515-596.
6. Bergmann M, Hart L, Lindsay M, Barnes PJ, Newton R (1998). IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-lbeta and tumor necrosis factor-alphainduced kappaB-dependent transcription. Requirement for an additional activation pathway, j Biol Chem 273: 6607-6610. (Pubitemid 28160316)
7. Birrell MA, Hardaker E, Wong S, McCluskie K, Catley M, De Alba J et al. (2005). Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am J Respir Crit Care Med 172: 962-971. (Pubitemid 41476532)
8. Bowie A, O'Neill LAJ (2000). The interleukin-1 receptor toll-like receptor superfamily: signal generation for proinflammatory interleukins and microbial products. J Leukoc Biol 67: 508-514. (Pubitemid 30679781)
9. Bradbury D, Clarke D, Seedhouse C, Corbett L, Stocks J, Knox A (2005). Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-I transcription factor binding sites. I Biol Chem 280: 29993-30000. (Pubitemid 41216174)
10. Chalmers GW, Little SA, Patel KR, Thomson NC (1997). Endothelin1-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 156: 382-388.
11. Chen P, Shibata M, Zidovetzki R, Fisher M, Zlokovic BV, Hofman FM (2001). Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures. J Neurolmmunol 116: 62-73. (Pubitemid 32322640)
12. Chintalgattu V, Katwa LC (2004). Role of protein kinase Cdelta in endothelin-induced type I collagen expression in cardiac myofibroblasts isolated from the site of myocardial infarction. J Pharmacol Exp Ther 311: 691-699. (Pubitemid 39391557)
13. Clarke DL, Belvisi MG, Catley MC, Yacoub MH, Newton R, Giembycz MA (2004). Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF. BrJPharmacol 141:1141-1150. (Pubitemid 38582251)
14. Clerk A, Sugden PH (1999). Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am J Cardiol 83: 64H-69H. (Pubitemid 29330931)
15. Clerk A, Michael A, Sugden PH (1998). Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J Cell Biol 142: 523-535. (Pubitemid 28361557)
16. Cullen JP, Sayeed S, Jin Y, Theodorakis NG, Sitzmann JV, Cahill PA et al. (2005). Ethanol inhibits monocyte chemotactic protein-1 expression in interleukin-l(beta}-activated human endothelial cells. Am J Physiol Heart Circ Physiol 289: H1669-H1675. (Pubitemid 41369011)
17. Davenport AP, Battistini B (2002). Classification of endothelin receptors and antagonists in clinical development. Clin Sci (Land) 103 (Suppl. 48): 1S-3S.
18. Dong C, Davis RJ, Flavell RA (2002). MAP kinases in the immune response. Annu Rev Immunol 20: 55-72.
19. Dragomir E, Tircol M, Manduteanu I, Volnea M, Simionescu M (2006). Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells. Vascul Pharmacol 44: 440-449. (Pubitemid 44235955)
20. Fehr JJ, Hirshman CA, Emala CW (2000). Cellular signaling by the potent bronchoconstrictor endothelin-1 in airway smooth muscle. Crit Care Med 28: 1884-1888. (Pubitemid 30428747)
21. Finsnes F, Skjonsberg OH, Lyberg T, Christensen G (2000). Endothelin-1 production is associated with eosinophilic rather than neutrophilic airway inflammation. Eur Respir J 15: 743-750. (Pubitemid 30196304)
22. Finsnes F, Lyberg T, Christensen G, Skjonsberg OH (2001). Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation. Am J Physiol Lung Cell Mol Physiol 280: L659-L665. (Pubitemid 32473166)
23. Fujitani Y, Bertrand C (1997). ET-1 cooperates with EGF to induce mitogenesis via a PTX-sensitive pathway in airway smooth muscle cells. Am J Physiol 272: C1492-C1498. (Pubitemid 27250385)
24. Fukuroda T, Ozaki S, Ihara M, Ishikawa K, Yano M, Miyauchi T et al. (1996). Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi. Br J Pharmacol 117: 995-999. (Pubitemid 126422073)
25. Goldie RG, Henry PJ, Knott PG, Self GJ, Luttmann MA, Hay DW (1995). Endothelin-1 receptor density, distribution, and function in human isolated asthmatic airways. Am J Respir Crit Care Med 152: 1653-1658.
26. Hall IP, Widdop S, Townsend P, Daykin K (1992). Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells. Br J Pharmacol 107: 422-428.
27. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L et al. (2001). c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 108: 73-81. (Pubitemid 32634924)
28. Harvey EJ, Li N, Ramji DP (2007). Critical role for casein kinase 2 and phosphoinositide-3-kinase in the interferon-gamma-induced expression of monocyte chemoattractant protein-1 and other key genes implicated in atherosclerosis. Arterioscler Thromb Vase Biol 27: 806-812. (Pubitemid 46606710)
29. Hay DW (1999). Putative mediator role of endothelin-1 in asthma and other lung diseases. Clin Exp Pharmacol Physiol 26: 168-171.
30. Hay DW, Hubbard WC, Undem BJ (1993). Endothelin-induced contraction and mediator release in human bronchus. Br J Pharmacol 110: 392-398.
31. Hay DW, Luttmann MA, Muccitelli RM, Goldie RG (1999). Endothelin receptors and calcium translocation pathways in human airways. Naunyn Schmiedebergs Arch Pharmacol 359: 404-410.
32. Henry PJ, Mann TS, D'Aprile AC, Self GJ, Goldie RG (2002). An endothelin receptor antagonist, SB-217242, inhibits airway hyperresponsiveness in allergic mice. Am J Physiol Lung Cell Mol Physiol 283: L1072-L1078.
33. Hocher B, Schwarz A, Fagan KA, Thone-Reineke C, El-Hag K, Kusserow H et al. (2000). Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am J Respir Celt Mol Biol 23: 19-26. (Pubitemid 30597091)
34. Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM (1997). Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 156: 1377-1383. (Pubitemid 27505497)
35. Ibarz G, Oiry C, Camazzi E, Crespy P, Escrieut C, Fourmy D et al. (2006). Cholecystokinin 1 receptor modulates the MEKKl-induced c-Jun trans-activation: structural requirements of the receptor. Br J Pharmacol 147: 951-958.
36. Ichihara S, Obata K, Yamada Y, Nagata K, Noda A, Ichihara G et al. (2006). Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors. J Mol Cell Cardiol 41: 318-329. (Pubitemid 44080222)
37. Ihara M, Ishikawa K, Fukuroda T, Saeki T, Funabashi K, Fukami T et al. (1992). In vitro biological profile of a highly potent novel endothelln (ET) antagonist BQ-123 selective for the ETA receptor. J Cardiovasc Pharmacol 20 (Suppl. 12): S11-S14. (Pubitemid 23014096)
38. Immervoll T, Loesgen S, Dutsch G, Gohlke H, Herbon N, Klugbauer S et al. (2001). Fine mapping and single nucleotide polymorphism association results of candidate genes for asthma and related phenotypes. Hum Mutat 18: 327-336. (Pubitemid 32916863)
39. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T et al. (1994). Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 91: 4892-4896. (Pubitemid 24177756)
40. Ishizawa K, Yoshizumi M, Tsuchiya K, Houchi H, Minakuchi K, Izawa Y et al. (2004). Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells. Hypertens Res 27: 433-440. (Pubitemid 38996934)
41. Jaramillo M, Godbout M, Naccache PH, Olivier M (2004). Signaling events involved in macrophage chemokine expression in response to monosodium urate crystals. J Biol Chem 279: 52797-52805. (Pubitemid 39656656)
42. Kieser A, Seitz T, Adler HS, Coffer P, Kremmer E, Crespo P et al. (1996). Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells. Genes Dev 10: 1455-1466. (Pubitemid 26260703)
43. Kisselera T, Bhattacharya S, Braunstein J, Schindler CW (2002). Signalling through the JAK/STAT pathway, recent advances and future challenges. Gene 285: 1-24. (Pubitemid 34246317)
44. Koyama S, Sato E, Numanami H, Kubo K, Nagai S, Izumi T (2000). Bradykinin stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activity. Am J Respir Cell Mol Biol 22: 75-84. (Pubitemid 30342962)
45. Liang F, Lu S, Gardner DG (2000). Endothelin-dependent and -independent components of strain-activated brain natriuretic peptide gene transcription require extracellular signal regulated kinase and p38 mitogen-activated protein kinase. Hypertension 35: 188-192. (Pubitemid 30054171)
46. Lim SP, Garzino-Demo A (2000). The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the betachemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites. J Virol 74: 1632-1640.
47. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B (1994). Monocyte chemotactic proteins MCI-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. FASEB J 8: 1055-1060. (Pubitemid 24979538)
48. Mao XQ, Gao PS, Roberts MH, Enomoto T, Kawai M, Sasaki S et al. (1999). Variants of endothelin-1 and its receptors in atopic asthma. Biochem Biophys Res Commun 262: 259-262. (Pubitemid 29412657)
49. Mullol J, Baraniuk JN, Logun C, Benfield T, Picado C, Shelhamer JH (1996). Endothelin-1 induces GM-CSF, IL-6 and 1L-8 but not G-CSF release from a human bronchial epithelial cell line (BEAS-2B). Neuropeptides 30: 551-556. (Pubitemid 27013981)
50. Nie M, Pang L, Inoue H, Knox AJ (2003). Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-lbeta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone h4 acetylation. Mol Cell Biol 23: 9233-9244. (Pubitemid 37499810)
51. Nie M, Corbett L, Knox AJ, Pang L (2005). Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2agonists. J Biol Chem 280: 2550-2561. (Pubitemid 40189357)
52. Nishikawa M, Myoui A, Tomita T, Takahi K, Nampei A, Yoshikawa H (2003). Prevention of the onset and progression of collageninduced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis Rheum 48: 2670-2681. (Pubitemid 37129445)
53. Pallisgaard N, Clausen N, Schroder H, Hokland P (1999). Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer 26: 355-365. (Pubitemid 29529581)
54. Panettieri RA Jr, Goldie RG, Rigby PJ, Eszterhas AJ, Hay DW (1996). Endothelin-1-induced potentiation of human airway smooth muscle proliferation: an ETA receptor-mediated phenomenon. Br J Pharmacol 118: 191-197. (Pubitemid 126423571)
55. Pang L, Knox AJ (1997). PGE2 release by bradykinin in human airway smooth muscle cells: involvement of cyclooxygenase-2 induction. Am J Physiol 273: L1132-L1140. (Pubitemid 127797997)
56. Pang L, Nie M, Corbett L, Knox AJ (2003). Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. J Immunol 170: 1043-1051. (Pubitemid 36070560)
57. Pang L, Nie M, Corbett L, Sutcliffe A, Knox AJ (2006). Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities. J Immunol 176: 3788-3795. (Pubitemid 43364027)
58. Podolin PL, Callahan JF, Bolognese BJ, Li YH, Carlson K, Davis TG et al. (2005). Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of lkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell Proliferation. J Pharmacol Exp Ther 312: 373-381. (Pubitemid 40096491)
59. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR (1991). Phosphorylation of c-jun mediated by MAP kinases. Nature 353: 670-674. (Pubitemid 21912588)
60. Ritchie MH, Fillmore RA, Lausch RN, Oakes JE (2004). A role for NF-kappa B binding motifs in the differential induction of chemokine gene expression in human corneal epithelial cells. Invest Ophthalmol Vis Sci 45: 2299-2305.
61. Rose CEJ, Sung SS, Fu SM (2003). Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10: 273-288.
62. Sato Y, Nishio Y, Sekine O, Kodama K, Nagai Y, Nakamura T et al. (2007). Increased expression of CCAAT/enhancer binding proteinbeta and -delta and monocyte chemoattractant protein-1 genes in aortas from hyperinsulinaemic rats. Diabetologia 50: 481-489.
63. Shapiro PS, Evans JN, Davis RJ, Posada JA (1996). The seventransmembrane-spanning receptors for endothelin and thrombin cause proliferation of airway smooth muscle cells and activation of the extracellular regulated kinase and c-Jun NH2-terminal kinase groups of mitogen-activated protein kinases. J Biol Chem 271: 57505754.
64. Shi-Wen X, Chen Y, Denton CP, Eastwood M, Renzoni EA, BouGharios G et al. (2004). Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 15: 27072719. (Pubitemid 38691860)
65. Sousa AR, Lane SJ, Nakhosteen JA, Yoshimura T, Lee TH, Poston RN (1994). Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol 10: 142-147.
66. Szalai C, Kozma GT, Nagy A, Bojszko A, Krikovszky D, Szabo T et al. (2001). Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 108: 375-381. (Pubitemid 32881058)
67. Teferedegne B, Green MR, Guo Z, Boss JM (2006). Mechanism of action of a distal NF-kappaB-dependent enhancer. Mol Cell Biol 26: 5759-5770. (Pubitemid 44134332)
68. Tsuchiya K, Yoshimoto T, Hirono Y, Tateno T, Sugiyama T, Hirata Y (2006). Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes. Am J Physiol Endocrinol Metab 291: E771-E778. (Pubitemid 44484919)
69. Vichi P, Whelchel A, Knot H, Nelson M, Kolch W, Posada J (1999). Endothelin-stimulated ERK activation in airway smooth-muscle cells requires calcium influx and Raf activation. Am J Respir Cell Mol Biol 20: 99-105. (Pubitemid 129504847)
70. Vignola AM, Kips J, Bousquet J (2000). Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 105: 1041-1053. (Pubitemid 30418779)
71. Vlahos CJ, Matter WF, HuI KY, Brown RF (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morphollnyl)-8-phenyl-4H-lbenzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248. (Pubitemid 2045363)
72. Watson ML, Grix SP, Jordan NJ, Place GA, Dodd S, Leithead J et al. (1998). Interleukin 8 and monocyte chemoattractant protein 1 production by cultured human airway smooth muscle cells. Cytokine 10: 346-352. (Pubitemid 28247896)
73. Whelchel A, Evans J, Posada J (1997). Inhibition of ERK activation attenuates endothelin-stimulated airway smooth muscle cell proliferation. Am J Respir Cell Mol Biol 16: 589-596. (Pubitemid 127498291)
74. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Demedts MG, Verleden GM (2003). Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-lbeta-induced chemokine release in human airway smooth muscle cells. Respir Med 97: 811-817. (Pubitemid 36763894)
75. Xu SW, Howat SL, Renzoni EA, Holmes A, Pearson JD, Dashwood MR etal. (2004). Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. J Biol Chem 279: 23098-23103.
76. Ye RD (2001). Regulation of nuclear factor kappaB activation by G-protein-coupled receptors. J Leukoc Biol 70: 839-848.
77. Yin J, Lee JA, Howells RD (1992). Stimulation of c-fos and c-jun gene expression and down-regulation of proenkephalin gene expression in C6 glioma cells by endothelin-1. Brain Res Mol Brain Res 14: 213-220.
78. Zachariae CO, Anderson AO, Thompson HL, Appella E, Mantovani A, Oppenheim JJ etal. (1990). Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med 171: 2177-2182.
79. Zhu YM, Bradbury DA, Pang L, Knox AJ (2003). Transcriptional regulation of interleukin (IL)-8 by bradykinin in human airway smooth muscle cells involves prostanoid-dependent activation of AP-1 and nuclear factor (NF)-IL-6 and prostanoid-lndependent activation of NF-kappaB. J Biol Chem 278: 29366-29375. (Pubitemid 36935854)